This new indication, based on the SOUL data, marks even further advancement and showcases the versatility of semaglutide while expanding options for millions of people." This new indication makes Rybelsus the only oral GLP-1 medicine approved to reduce the risk of MACE in adults with type 2 diabetes who are at high risk for these events
However, the metabolic and weight changes it induces can create a cascade of hormonal adjustments that manifest as menstrual irregularities
Its not, however, licensed as a fertility treatment, and youd need to stop the medication at least one month before trying to conceive
doi: 10.1016/j.rmed.2019.06.015 46 KuHCChenWPSuMJ
GLP-1 agonists can be a powerful tool to manage diabetes and control weight, but like any medication, theyre not without risks, so talking with your doctor is always a good choice.